Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. (Q39922923)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

Adaptive radiation therapy

25 December 2019

main subject

0 references

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

H J Mauceri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M A Beckett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

H Liang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

H G Sutton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Pitroda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

E Galka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

E Efimova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

N N Khodarev

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C R King

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M C Posner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Hellman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

D W Kufe

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

R R Weichselbaum

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

31 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

373-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2008.86

25 December 2019

exact match

0 references

cites work

Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Inflammation, inflammatory cells and angiogenesis: decisions and indecisions

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Smac mimetics and TNFalpha: a dangerous liaison?

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Tumor promotion by tumor-associated macrophages

17 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

17 June 2018

https://api.crossref.org/works/10.1038%2FCGT.2008.86

7 January 2021

inferred from DOI database lookup

Influence of tumor cell and stroma sensitivity on tumor response to radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Tumor cell radiosensitivity is a major determinant of tumor response to radiation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Inflammation and cancer: how hot is the link?

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

TNF-R1 signaling: a beautiful pathway

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

TNF receptor subtype signalling: differences and cellular consequences

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

The two different receptors for tumor necrosis factor mediate distinct cellular responses

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

An endotoxin-induced serum factor that causes necrosis of tumors

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Induction and immunological properties of tumor necrosis factor

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Spatial and temporal control of gene therapy using ionizing radiation

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5705082

Tumor response to radiotherapy regulated by endothelial cell apoptosis

20 August 2018

1 reference

12 December 2020

Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung

1 reference

12 December 2020

Tumor necrosis factor

1 reference

12 December 2020

Building in resistance to endothelial cell death

1 reference

12 December 2020

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease

1 reference

12 December 2020

Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55

1 reference

12 December 2020

Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (I)

1 reference

12 December 2020

Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents

1 reference

12 December 2020

Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (II)

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity

1 reference

12 December 2020

Identifiers

DOI

10.1038/CGT.2008.86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18974777%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference